Medison is one of the world’s largest commercial partners of leading global biotech companies. Medison is uniquely qualified to provide the complete spectrum of integrated services for biotech companies looking to enter or expand their presence in Israel, Canada, and Central Eastern Europe. Medison runs a corporate venture arm with a dedicated research and evaluation team boasting deep scientific and commercial backgrounds. Medison also operates a scouting program to cater its partners and is an active investor in life science projects around drug development and digital health.
Meir Jakobsohn founded Medison in 1996 and has been serving as its CEO since the company’s inception, spearheading Medison’s growth and transformation into a global pharma company. Meir is the third generation of his family in the healthcare industry. Prior to founding Medison, Meir served as the COO of M. Jakobsohn Ltd., led by Arie Jakobsohn, which represented Ciba-Geigy (Novartis) between 1937 and 1995. Meir leads a variety of multiple philanthropic projects focusing on education and social welfare.
Sharon Alon is Medison Israel’s General Manager and is responsible for all of Medison’s pharma operations in the Israeli market and the ongoing relationship with Medison’s partners. Sharon brings broad experience in business strategy coupled with innovative thinking and implementation of digital transformation.
Prior to joining Medison, Sharon served as the Managing Director of MSD Israel for almost seven years, as MSD Israel’s Primary Care Business Unit Director and was Business Unit Director – Nutritional Division at Abbott Israel.
Gil Gurfinkel is responsible for formulating and executing Medison’s global strategic development and the company’s business development processes. Gil is also the Managing Partner of Medison Ventures, the corporate venture arm of Medison.
Gil brings vast experience in business strategy, management consulting, corporate finance, private equity and capital markets. Prior to joining Medison, Gil was Vice President at the private equity fund Shamrock, where he led multiple investments and acted as a chairman and board member of multiple international companies.
Ron Goldstein is responsible for managing Medison’s global financial operation. Prior to this position, Ron served as Medison’s Chief of Staff and was responsible for managing and fusing cross-organizational processes. Prior to joining Medison, Ron was Vice President at Shamrock, a private equity fund and a consultant at KPMG Corporate Finance Israel.
Adv. Yoel Lipschitz is responsible for Medison’s global policy, pharmaceutical and medical devices regulations, quality, PV, pricing, and technology assessments, as well as managing market access strategy and its execution. Yoel has many years of experience as a senior executive in governmental authorities, in legal and regulatory positions. Prior to joining Medison, Yoel was Deputy Director General for Health Care Organizations & Supplementary Insurance at the Ministry of Health and was a member of the National Health Services Committee.
Prof. Amos Pines is responsible for Medison’s global medical related matters. Amos also serves as a Clinical Associate Professor at Tel Aviv University’s Sackler School of Medicine. Amos brings extensive experience in conducting clinical trials for multinational companies and has published over 100 studies in prestigious medical journals. Prof. Pines holds a B.Sc. in Biology from the Hebrew University of Jerusalem, and an M.D. from Hadassah Medical School, Jerusalem.
Ofir Tessel is responsible for Medison’s global information systems, digital transformation, cybersecurity, data and technology. Ofir has vast experience in business transformation led by technology, digital and innovative solutions. Prior to joining Medison, Ofir held various senior roles in leading global technology companies, including Senior Strategic Digital Advisor at Microsoft, establishing the Digital & Innovation consulting practice at EY Israel, and Senior Account Executive at SAP.
Yael Zidky is responsible for establishing the company’s global policies, procedures, compensation structures, organizational development, recruitment, and benefits. In addition, Yael is also responsible for the development and implementation of Medison’s compliance programs ensuring complete correlation with partners in all related ethical matters. Prior to joining Medison, Yael served as Vice President of Human Resources at IXI Mobile Inc., and other global technology companies.
Vision & Values
Driven by a mission to be the leading single address for partners and customers in Israel, CEE, and Canada and to nurturing long-term employee loyalty and development, Medison strives to deliver innovative high-quality products to patients in order to save lives and improve the quality of life.
WE STRIVE TO DELIVER THE MOST INNOVATIVE AND UNIQUE HEALTHCARE SOLUTIONS TO PATIENTS.
Quality Policies and Certificates
Facts & Figures
- Founded in 1996
- Led by the third generation of the Jakobsohn family, pharmaceutical industry pioneers in Israelת since 1937
- Track record of maintaining long-term franchising, exceeding two decades, of small-to-medium-sized pharmaceutical companies
- Among the top 3 pharmaceutical companies in Israel by sales
- Over $170M sales revenues in 2017
- Full spectrum of services including registration, reimbursement, nursing, distribution, marketing, NIH, and more
- Upholds international standards of corporate governance, ethics and stringent transparency
- Operates in full compliance with GDP, cGMP and ISO standards
10 Hashiloach St. P.O.B 7090
Petach Tikva, 4917002, Israel